#-supreme-cellcarta-differentiators-3-106{items-data:[{"text":"Capacités multi-omiques"},{"text":"Développement de tests personnalisés"},{"text":"Exécution mondiale"},{"text":"Expertise en biomarqueurs"},{"text":"Flux de travail collaboratifs"}]}#-supreme-cellcarta-overview-17-123{stats-data:[{"number":"25+ ","label":"Années d'expertise"},{"number":"8 ","label":"Installations à l'échelle mondiale"},{"number":"750+ ","label":"Employés"}]}#-supreme-cellcarta-service-cards-16-106{cards-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-19-scaled.jpg","image_alt":"","title":"Modalités Thérapeutiques","description":"Expertise en biomarqueurs pour le développement des ADC,des thérapies cellulaires et des DCP.","links":"Sub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #","link1_label":"","link1_url":"","link2_label":"Conjugués anticorps-médicament","link2_url":"/fr/expertises-therapeutiques/modalites/conjugues-anticorps-medicament/","link3_label":"Thérapies cellulaires","link4_label":"Dégradeurs de protéines cibles ","link4_url":"/fr/expertises-therapeutiques/modalites/degradeurs-de-proteines-cibles/","link3_url":"/fr/expertises-therapeutiques/modalites/therapies-cellulaires/","card_link_url":"/fr/expertises-therapeutiques/modalites-therapeutiques/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/Autoimmune-Diseases-hero-457.jpg","image_alt":"","title":"Maladies auto-immunes","description":"Tests mesurant la normalisation de la dérégulation immunitaire auto-réactive en lien avec le mécanisme d'action du médicament.","links":"Sub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #","link1_label":"","link1_url":"","link2_label":"","link2_url":"","link3_label":"","link3_url":"","link4_label":"","link4_url":"","link5_label":"","link5_url":"","card_link_url":"/fr/expertises-therapeutiques/maladies-auto-immunes/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/89-IMG_2591-1-scaled.jpg","image_alt":"","title":"Immunologie","description":"Analyses sur le remodelage du paysage immunitaire au cours d'une intervention d'immunothérapie.","links":"Sub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #","link1_label":"","link1_url":"","link2_label":"","link2_url":"","card_link_url":"/fr/expertises-therapeutiques/immunologie/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/Infectious-Diseases-hero-577.jpg","image_alt":"","title":"Maladies infectieuses","description":"Suivi des réponses aux programmes thérapeutiques vaccinaux et autres programmes liés aux maladies infectieuses.","links":"Sub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #","link1_label":"","link1_url":"","link2_label":"","link2_url":"","card_link_url":"/fr/expertises-therapeutiques/maladies-infectieuses/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-6-scaled.jpg","image_alt":"","title":"Neurosciences ","description":"Tests protéomiques du LCR,du plasma et des tissus cérébraux pour les programmes liés aux maladies neurologiques.","links":"","link1_label":"","link1_url":"","card_link_url":"/fr/expertises-therapeutiques/neurosciences/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Oncology-Hero-605.jpg","image_alt":"","title":"Oncologie","description":"Des solutions couvrant le suivi immunitaire,l'histopathologie et la spectrométrie de masse.","links":"","link1_label":"","link1_url":"","card_link_url":"/fr/expertises-therapeutiques/oncologie/"}]}